Dergiler / Haseki Tıp Bülteni / 2020 / Cilt: 58 - Sayı: 2

The Relationship Between Serum Vaspin Levels and the Degree of Coronary Involvement in Patients with Stable Angina Pectoris

Stabil Angina Pektorisli Hastalarda Serum Vaspin Düzeyleri ile Damar Tutulum Derecesi Arasindaki İlişki

Sayfa
176–182
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The underlying cause is probably lack of significant changes in inflammatory cascade and oxidative stress in the involved group of patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Vaspin is an insulin-sensitive adipokine secreted from visceral fat tissue, and belongs to the serine protease inhibitor family.
📊
Temel Bulgular & Veri:Results: Eighty-eight patients [34 female (38.6%) and 54 male (91.4%)] were included in the study.
💡
Sonuç & Katkı:The underlying cause is probably lack of significant changes in inflammatory cascade and oxidative stress in the involved group of patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Aim: Vaspin is an insulin-sensitive adipokine secreted from visceral fat tissue, and belongs to the serine protease inhibitor family. The relationship between vaspin level and coronary artery disease is not known yet. We aimed to investigate the relationship between serum vaspin levels and degree of vessel involvement in coronary angiography in patients with stable angina pectoris. Methods: The patients were chosen from those who had coronary angiography with the diagnosis of stable angina pectoris. Patients with previously diagnosed chronic heart disease, chronic liver disease, renal failure, thyroid dysfunction and any systemic infectious or malignant disease, patients receiving immunosupressive treatment and those who did not give informed consent were excluded from the study. Serum vaspin measurements were performed using an East Biopharm enzyme-linked immunoassay (ELISA) kit using the sandwich ELISA method. For determination of the severity of coronary lesions, the modified Gensini score was used. Results: Eighty-eight patients [34 female (38.6%) and 54 male (91.4%)] were included in the study. Vaspin levels were similar in male (1.17±1.54 ng/L) and female (1.09±1.23 ng/L) patients (p=0.46). There was no correlation between vaspin levels and the number of vessels involved (p=0.75). Vaspin levels were similar in diabetic and nondiabetic patients. Conclusion: Vaspin may not be a sensitive marker of the degree of vascular lesions in patients with stable angina pectoris. The underlying cause is probably lack of significant changes in inflammatory cascade and oxidative stress in the involved group of patients.

Abstract

Amaç: Vaspin, serin proteaz ailesinden, insulin duyarlı bir adipokin olup visseral yağ dokudan salınmaktadır. Serum vaspin düzeyi ile koroner arter hastalığı arasında ilişki olup olmadığı henüz bilinmemektedir. Çalışmamızda, serum vaspin düzeylerinin koroner anjiografi yapılmış stabil anjina pektorisli hastalarda damar tutulum dereceleri ile ilişkisini araştırmayı amaçladık. Yöntemler: Hastalar, stabil anjina pektoris tanısı ile koroner anjiografi yapılmış hastalar arasından seçildi. Bilinen kronik kalp hastalığı, kronik karaciğer hastalığı, böbrek yetmezliği, tiroit disfonksiyonu olan, immünsüpresif tedavi alan, herhangi bir sistemik enfeksiyöz veya malign hastalığı olanlar ile onam formu vermeyenler çalışmaya alınmadı. Serum vaspin ölçümleri sandviç enzim bağlı immün ölçüm (ELISA) metodu kullanarak east biopharm ELISA kiti ile yapıldı. Koroner lezyonların şiddeti modifiye Gensini skoru kullanılarak belirlendi. Bulgular: Çalışmaya seksen sekiz hasta [34 kadın (%38,6) ve 54 erkek (%91,4)] dahil edildi. Vaspin düzeyleri erkeklerde (1,17±1,54 ng/L) ve kadınlarda (1,09±1,23 ng/L) benzerdi. (p=0,46). Vaspin düzeyleri tutulan damar sayısı ile korele değildi (p=0,75). Vaspin düzeyleri diyabetik ve diyabetik olmayan hastalarda benzer seviyelerde idi. Sonuç: Vaspin, stabil anjina pektorisli hastalarda damar tutulum derecesi için hassas bir belirteç olmayabilir. Bunun nedeni dahil edilen grupta enflamatuvar kaskatta ve oksidatif streste belirgin değişim olmaması olabilir

🔖

Bu Makaleye Atıf Yap

BOZACI, İ., ÖZKAN, O., ÖZKAN, A. A., KOLDAŞ, M., ÖZTÜRK, S. (2020). The Relationship Between Serum Vaspin Levels and the Degree of Coronary Involvement in Patients with Stable Angina Pectoris. Haseki Tıp Bülteni, Cilt: 58 - Sayı: 2, 176–182. https://ajindex.com/articles/267769

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Geovanini GR, Libby P. Atherosclerosis and Inflammation. Overview and Updates.Clin Sci (Lond) 2018;132:1243-52
  2. Strain WD,Paldanius PM.Diabetes,cardiovascular disease and Microcirculation. Cardiovasc Diabetol 2018;17:57
  3. Koenig W. C-Reactive Protein and Cardiovascular Risk: Will the Controversy End After CANTOS.Clin Chem 2017;63:1897-8
  4. Ganguly P,Alam SF.Role of Homocysteine in the Development of Cardiovascular Disease.Nutr J 2015;14:6
  5. Hida K, Wada J, Eguchi J, et al. Visceral adipose tissuederived serine protease inhibitor: a unique insulinsensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 2005;102:10610-5
  6. Aust G, Richter O, Rohm S, et al. Vaspin serum consantrations in patients with carotid stenosis. Aterosclerosis 2008;204:262-6
  7. Shaker OG, Sadik NA.Vaspin gene in rat adipose tissue:relation to obesity-iduced insulin resistance.Moll Cell Biochem 2013;373:229-39
  8. Chang HM, Lee HJ, Park HS, et al. Effects of weight reduction on serum vaspin concentrations in obese subjects:modification by insulin resistance. Obesity (Silver Spring) 2010;18:2105-10
  9. Lane DM. Third Report of the National Cholesterol Education Program (NCEP.III): A Switch From Dietary Modification to Risk Factor Assessment. Curr Opin Investig Drugs 2001;2:1235-6
  10. Mahley RW, Pepin GM, Bersot TP, Palaoglu KE, Ozer K. Türk Kalp Çalışmasında Yeni Sonuçlar.Plazma Lipidleri ve Yüksek Yoğunluklu Lipoprotein Düzeyleri Düşüklüğünde Tedavi için Rehber Öneriler.Türk Kardiyoloji Derneği Araş 2002;30:93- 103
  11. Yumuk V, Tsigos J, Fried M, et al. European Guidelines for Obesity Managements in Adults.Obese Facts 2015;8:402-24
  12. Grundy Scott M, Cleeman James I, Daniels Stephen R, et al. Diagnosis and The Management of Metabolic Syndrome Circulation 2005;112:2735-52
  13. Lind L, Amlov J, Lampa E. The Interplay Between Fat Mass and Fat Distribution as Determinants of the Metabolic Syndrome is Sex-Dependant.Metab Syndr Relat Disord 2017;15:337-43
  14. Longo M, Zatterale F, Naderi J, et al. Adipose Tissues Dysfuction as Determinant of Obesity-Associated Metabolic Complications. Int J Mol Sci 2019;20.pii:E2358 15. Hosseini-Esfahani F, Bahadoran Z, Moslehi N, et al. Metabolic Syndrome: Findings from 20 Years of The Tehran Lipid and Glucose Study.Int J Endocrinol Metab 2018;16(4 Suppl):e84771
  15. Patel A, Thompson A, Abdelmalek L, Adams-Huet B, Jialal I. The Relationship Between Tyramine Levels and Inflammation in Metabolic Syndrome. Horm Mol Biol Clin Investig 2019